Navigation Links
BioStorage Technologies Serves as Repository for Landmark Study of Coronary Artery Disease
Date:7/23/2008

INDIANAPOLIS, July 23 /PRNewswire/ -- BioStorage Technologies, Inc. (BST) will serve as the biorepository partner for the first phase of the Indiana Health Study, a new landmark longitudinal study of coronary artery disease. This community-based research initiative will utilize the population of Indianapolis and surrounding areas as study participants and will enable research that will lead to new drugs and diagnostics that allow doctors to better manage common, chronic diseases such as heart disease, cancer and diabetes.

Sponsored by the Fairbanks Institute for Healthy Communities, an Indianapolis-based nonprofit organization, the Indiana Health Study will create one of the nation's most comprehensive resources for academic and commercial research by integrating biological samples, medical data and lifestyle information collected from two cohorts of people: patients with coronary artery disease and people without the disease.

The collected biological samples will be stored at BST's state-of-the-art facility located in Indianapolis. "We selected BioStorage because of their expertise in cold chain logistics, sample management and long term storage, which are all necessities for a study of this scope and importance," said Dr. Cynthia Helphingstine, president and COO of the Fairbanks Institute. "We are fortunate to have partnered with a company that shares our strong commitment for community-based life science research."

Dr. John F. Mills, M.D., Ph.D., chief executive officer of BioStorage Technologies believes the Indiana Health Study can make a significant impact on the future of health care for people in Indiana and around the world. "We believe we can play a vital role in advancing health care and research initiatives through ensuring sample integrity. In a study of this magnitude samples are vital and could possibly hold the key to unlocking the causes of some of this nation's deadliest diseases."

While the Indiana Health Study will follow participants for years, Helphingstine anticipates immediate benefits as well. Samples will be available for researchers as soon as they are collected. The Fairbanks Institute intends to study multiple chronic diseases with future research platforms including studies on cancer, diabetes and central nervous system disorders.

About BioStorage Technologies, Inc.:

BioStorage Technologies, Inc. is a leader in sample storage, inventory management and coldchain logistics for the biotechnology and pharmaceutical industries. The company offers secure, temperature-controlled storage; real-time tracking of stored biological samples; and next-day return of biomaterials. BioStorage Technologies is privately-held and headquartered in Indianapolis with an additional full-service site near Frankfurt, Germany. For more information, visit http://www.biostorage.com or call +1 (866) 697-2675 or +49-6155-898-1010.

About Fairbanks Institute

Formed with a $10 million gift from the Richard M. Fairbanks Foundation and the collaboration of BioCrossroads, Indiana University School of Medicine, Regenstrief Institute and other Indianapolis community health leaders, Fairbanks Institute is creating one of the nation's most comprehensive resources for finding better ways to prevent, diagnose and treat the nation's most common, chronic diseases.

Press Contact:

Whitney Dean

Miller Brooks, Inc.

317-873-8100

whitney@millerbrooks.com


'/>"/>
SOURCE BioStorage Technologies, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. BioStorage Technologies Announces Platinum Sponsorship of Biorepositories 2008
2. BioStorage Technologies Forms Scientific Advisory Board with Leading Life Science Experts
3. BioStorage Technologies Appoints Dr. Wolfgang Hoffer as Managing Director of European Operations
4. BioStorage Technologies Appoints Lori Ball as Vice President
5. BioStorage Technologies Becomes Green Powered through the Use of 100% Certified Renewable Energy
6. Hologic, Inc. Accepts Shares of Third Wave Technologies, Inc. in Tender Offer and Commences Subsequent Offering Period
7. MacroGenics Acquires Raven Biotechnologies
8. Netsmart Technologies Web Seminar Helps Behavioral Health Organizations Understand Electronic Prescribing and the Importance of New Medicare-Related E-Prescribing Legislation
9. FDA Grants Epeius Biotechnologies Rexin-G a Third Orphan Drug Designation, This Time for the Treatment of Soft Tissue Sarcomas
10. Epeius Biotechnologies Tumor-Targeted Rexin-G Receives FDA Orphan Drug Designation for the Treatment of Osteosarcoma
11. Senesco Technologies Closes Remaining $3.0 Million of Previously Announced Financing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... Mass. , June 23, 2016   ... development of novel compounds designed to target cancer ... napabucasin, has been granted Orphan Drug Designation from ... the treatment of gastric cancer, including gastroesophageal junction ... stemness inhibitor designed to inhibit cancer stemness pathways ...
(Date:6/23/2016)... , June 23, 2016 Houston ... with the Cy-Fair Sports Association to serve as ... the agreement, Houston Methodist Willowbrook will provide sponsorship ... and connectivity with association coaches, volunteers, athletes and ... with the Cy-Fair Sports Association and to bring ...
(Date:6/23/2016)... -- The Biodesign Challenge (BDC), a university competition that asks ... systems and biotechnology, announced its winning teams at the ... York City . The teams, chosen ... MoMA,s Celeste Bartos Theater during the daylong summit. Keynote ... of architecture and design, and Suzanne Lee , ...
(Date:6/23/2016)... ... June 23, 2016 , ... STACS DNA Inc., the sample tracking software company, ... Crime Laboratory, has joined STACS DNA as a Field Application Specialist. , “I ... President and COO of STACS DNA. “In further expanding our capacity as a scientific ...
Breaking Biology Technology:
(Date:5/16/2016)... 2016   EyeLock LLC , a market leader ... of an IoT Center of Excellence in ... development of embedded iris biometric applications. EyeLock,s ... and security with unmatched biometric accuracy, making it the ... DNA. EyeLock,s platform uses video technology to deliver a ...
(Date:4/28/2016)... April 28, 2016 First quarter 2016:   ... 966% compared with the first quarter of 2015 The ... 589.1 M (loss: 18.8) and the operating margin was 40% (-13) ... Cash flow from operations was SEK 249.9 M (21.2) ... guidance is unchanged, SEK 7,000-8,500 M. The operating margin ...
(Date:4/15/2016)... April 15, 2016 Research ... Gait Biometrics Market 2016-2020,"  report to their offering.  ... ) , ,The global gait biometrics market is ... during the period 2016-2020. Gait analysis ... can be used to compute factors that are ...
Breaking Biology News(10 mins):